<DOC>
	<DOCNO>NCT02693691</DOCNO>
	<brief_summary>The purpose study characterize use CardioMEMS™ HF System use real-world setting .</brief_summary>
	<brief_title>CardioMEMS European Monitoring Study Heart Failure</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Indicated receive CardioMEMS sensor implant per CardioMEMS™ HF System User 's Manual &gt; 18 year age Diagnosis New York Heart Association ( NYHA ) Class III Heart Failure time sensor implantation Hospitalization worsen HF , define protocol , within 12 month prior CardioMEMS HF System implant Subjects reduce Left Ventricular Ejection Fraction ( LVEF ) must stable Guideline Directed Medical Therapy ( GDMT ) tolerate Written inform consent obtain subject Known coagulation disorder inability take two type blood thin medication one month sensor implanted Subjects deem candidate transplant , Ventricular Assist Device , hospice care next 12 month otherwise expect able complete study follow</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>